Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus - PubMed (original) (raw)
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus
John A Evans et al. Clin Gastroenterol Hepatol. 2006 Jan.
Abstract
Background & aims: Optical coherence tomography (OCT) is an optical technique that produces high-resolution images of the esophagus during endoscopy. OCT can distinguish specialized intestinal metaplasia (SIM) from squamous mucosa, but image criteria for differentiating intramucosal carcinoma (IMC) and high-grade dysplasia (HGD) from low-grade dysplasia (LGD), indeterminate-grade dysplasia (IGD), and SIM without dysplasia have not been validated. The purpose of this study was to establish OCT image characteristics of IMC and HGD in Barrett's esophagus.
Methods: Biopsy-correlated OCT images were acquired from patients with Barrett's esophagus undergoing endoscopic surveillance. Two pathologists rendered consensus diagnoses of the biopsy specimens. A blinded investigator reviewed the biopsy-correlated OCT images and scored each for surface maturation and gland architecture. For each image the scores were summed to determine an OCT "dysplasia index."
Results: A total of 177 biopsy-correlated images were analyzed. The corresponding histopathology diagnosis was IMC/HGD in 49 cases, LGD in 15, IGD in 8, SIM in 100, and gastric mucosa in 5. A significant relationship was found between a histopathologic diagnosis of IMC/HGD and scores for each image feature (dysplasia index [Spearman correlation coefficient, r = 0.50, P < .0001], surface maturation [r = 0.48, P < .0001], and gland architecture [r = 0.41, P < .0001]). When a dysplasia index threshold of >or=2 was used, the sensitivity and specificity for diagnosing IMC/HGD were 83% and 75%, respectively.
Conclusions: An OCT image scoring system based on histopathologic characteristics has the potential to identify IMC and HGD in Barrett's esophagus.
Figures
Figure 1
OCT images of SIM with and without IMC/HGD. (A) OCT image of SIM without dysplasia demonstrates glandular architecture with a relatively low reflectivity. (B) Corresponding histology to (A) with inset demonstrates a low nuclear to cytoplasm ratio in the superficial epithelium. (C) OCT image of IMC/HGD enables visualization of large and irregular glands (arrows). (D) Irregular, dilated glands are also seen in the corresponding histology to (C) (arrows). (E) OCT image of IMC/HGD shows a disorganized architecture and increased surface reflectivity (arrows). (F) Corresponding histology for (E) demonstrates abnormal glandular architecture and an increased superficial nuclear to cytoplasm ratio (inset). Histology: hematoxylin-eosin; original magnification, 40 ×. Scale bars, 500 μm.
Comment in
- Detecting dysplasia with optical coherence tomography.
Wallace MB. Wallace MB. Clin Gastroenterol Hepatol. 2006 Jan;4(1):36-7. doi: 10.1016/j.cgh.2005.10.005. Clin Gastroenterol Hepatol. 2006. PMID: 16431302 No abstract available.
Similar articles
- Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I. Chennat J, et al. Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24. Gastrointest Endosc. 2009. PMID: 19555948 - Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
Small AJ, Sutherland SE, Hightower JS, Guarner-Argente C, Furth EE, Kochman ML, Forde KA, Bewtra M, Falk GW, Ginsberg GG. Small AJ, et al. Gastrointest Endosc. 2015 May;81(5):1158-66.e1-4. doi: 10.1016/j.gie.2014.10.029. Epub 2015 Jan 31. Gastrointest Endosc. 2015. PMID: 25650071 - Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I. Chennat J, et al. Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18. Am J Gastroenterol. 2009. PMID: 19690526 - The diagnosis and management of Barrett's esophagus.
DeMeester SR, DeMeester TR. DeMeester SR, et al. Adv Surg. 1999;33:29-68. Adv Surg. 1999. PMID: 10572561 Review. - Performance characteristics of optical coherence tomography in assessment of Barrett's esophagus and esophageal cancer: systematic review.
Kohli DR, Schubert ML, Zfass AM, Shah TU. Kohli DR, et al. Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox049. Dis Esophagus. 2017. PMID: 28881898 Review.
Cited by
- Recent development of optical coherence tomography for preoperative diagnosis of esophageal malignancies.
Uno K, Koike T, Shimosegawa T. Uno K, et al. World J Gastrointest Endosc. 2015 Jul 25;7(9):872-80. doi: 10.4253/wjge.v7.i9.872. World J Gastrointest Endosc. 2015. PMID: 26240688 Free PMC article. Review. - Emerging optical methods for surveillance of Barrett's oesophagus.
Sturm MB, Wang TD. Sturm MB, et al. Gut. 2015 Nov;64(11):1816-23. doi: 10.1136/gutjnl-2013-306706. Epub 2015 May 14. Gut. 2015. PMID: 25975605 Free PMC article. Review. - Assessment of Barrett's esophagus and dysplasia with ultrahigh-speed volumetric en face and cross-sectional optical coherence tomography.
Ahsen OO, Liang K, Lee HC, Giacomelli MG, Wang Z, Potsaid B, Figueiredo M, Huang Q, Jayaraman V, Fujimoto JG, Mashimo H. Ahsen OO, et al. Endoscopy. 2019 Apr;51(4):355-359. doi: 10.1055/a-0725-7995. Epub 2018 Sep 27. Endoscopy. 2019. PMID: 30261534 Free PMC article. - Advanced imaging technologies for the detection of dysplasia and early cancer in barrett esophagus.
Espino A, Cirocco M, Dacosta R, Marcon N. Espino A, et al. Clin Endosc. 2014 Jan;47(1):47-54. doi: 10.5946/ce.2014.47.1.47. Epub 2014 Jan 24. Clin Endosc. 2014. PMID: 24570883 Free PMC article. Review. - Endoscopic imaging of Barrett's esophagus.
Naveed M, Dunbar KB. Naveed M, et al. World J Gastrointest Endosc. 2016 Mar 10;8(5):259-66. doi: 10.4253/wjge.v8.i5.259. World J Gastrointest Endosc. 2016. PMID: 26981177 Free PMC article. Review.
References
- Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289. - PubMed
- Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol. 1999;94:86–91. - PubMed
- Devesa SS, Blot WJ, Fraumeni JF., Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053. - PubMed
- Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831. - PubMed
- Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310–330. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical